logo

DSP Healthcare Fund - Regular Plan - Growth

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 05-11-2018
AUM:

₹ 2,363.39 Cr

Expense Ratio

2.0%

Benchmark

S&P BSE Healthcare TRI

ISIN

INF740KA1LD8

Minimum Investment

100.0

Minimum Topup

100.0

Minimum SIP Amount

500

Fund Manager

Jay Kothari, Chirag Dagli

Fund Performance 1Y (%) 3Y (%) 5Y (%)
DSP Healthcare Fund - Regular Plan - Growth 45.58 15.61 27.95
S&P BSE Healthcare TRI 50.08 13.58 22.23
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
33.381
Last change
0.34 (1.0185%)
Fund Size (AUM)
₹ 2,363.39 Cr
Performance
24.22% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Fund Manager
Jay Kothari, Chirag Dagli
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
Sun Pharmaceutical Industries Ltd. 12.59
Cipla Ltd. 8.49
Ipca Laboratories Ltd. 7.82
Suven Pharmaceuticals Ltd. 7.56
Lupin Ltd. 7.32
Alembic Pharmaceuticals Ltd. 5.56
Globus Medical Inc 5.51
Apollo Hospitals Enterprise Ltd. 4.6
Zydus Lifesciences Ltd. 4.39
Concord Biotech Ltd. 3.87

Sector Allocation

Sector Holdings (%)
Healthcare 96.26
Insurance 1.61
Others 1.25
Financial 0.88